CIK 0001412486 · Non-accelerated filer<br>Smaller reporting company
Cocrystal Pharma, Inc.
Sign in to watch- Ticker
- COCP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 352528215
- Phone
- (786) 459-1831
- Business address
- 19805 N. CREEK PARKWAY, BOTHELL, WA, 98011
- Former names
- BIOZONE PHARMACEUTICALS, INC., International Surf Resorts, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-03-23 | Meckler Jeffrey A Director | Grant or award · Stock Option (Right to Buy) | +1,750,000 | 1,750,000 | ||
| 2015-03-03 | Rubin Steven D Director | Option exercise | +109,920 | 639,920 | ||
| 2015-03-03 | Rubin Steven D Director | Option exercise · Series B Convertible Preferred Stock | −536 | 0 | ||
| 2015-03-03 | HSIAO JANE PH D Director | Option exercise | +5,496,654 | 5,496,654 | ||
| 2015-03-03 | HSIAO JANE PH D Director | Option exercise · Series B Convertible Preferred Stock | −53,626,802 | 0 | ||
| 2015-03-03 | WILCOX GARY CHIEF EXECUTIVE OFFICER | Option exercise | +16,835,237 | 16,835,237 | ||
| 2015-03-03 | WILCOX GARY CHIEF EXECUTIVE OFFICER | Option exercise · Series B Preferred Stock | −82,090 | 0 | ||
| 2015-03-03 | Lee Sam PRESIDENT | Option exercise | +15,287,847 | 15,287,847 | ||
| 2015-03-03 | Lee Sam PRESIDENT | Option exercise · Series B Preferred Stock | −74,545 | 0 | ||
| 2015-03-03 | FROST PHILLIP MD ET AL Director | Option exercise | +87,726,389 | 100,094,114 | ||
| 2015-03-03 | FROST PHILLIP MD ET AL Director | Option exercise · Series B Convertible Preferred Stock | −427,760 | 0 | ||
| 2015-03-03 | Schinazi Raymond F Director | Option exercise | +269,114,822 | 269,114,822 | ||
| 2015-03-03 | Schinazi Raymond F Director | Option exercise · Series A Convertible Preferred Stock | −789,747 | 0 | ||
| 2014-12-15 | FROST PHILLIP MD ET AL Director | Purchase | +6,127 | $0.43 | $3K | 12,348,852 |
| 2014-12-15 | FROST PHILLIP MD ET AL Director | Purchase | +8,873 | $0.43 | $4K | 12,357,725 |
| 2014-12-15 | FROST PHILLIP MD ET AL Director | Purchase | +10,000 | $0.44 | $4K | 12,367,725 |
| 2014-12-11 | Meckler Jeffrey A Director | Purchase | +25,000 | $0.45 | $11K | 25,000 |
| 2014-12-11 | Meckler Jeffrey A Director | Purchase | +25,000 | $0.45 | $11K | 50,000 |
| 2014-12-11 | Meckler Jeffrey A Director | Purchase | +50,000 | $0.46 | $23K | 100,000 |
| 2014-11-25 | Schinazi Raymond F Director | Grant or award · Series A Convertible Preferred Stock | +798,747 | 798,747 |
Page 7 of 8 · 145 trades